A model of herpes simplex virus type 2 (HSV-2) infection was developed in the guinea-pig that permits investigation of the role of neural spread of virus in the pathogenesis of genital skin disease. After HSV-2 inoculation of an abraded area lateral to the external genital skin, virus was first detected in the ipsilateral (to the inoculation site) peripheral nerves or genital skin on day 2 or 3 post-inoculation followed by detection in the ipsilateral dorsal root ganglia and spinal cord on day 3 or 4. Virus also spread to the contralateral dorsal root ganglia, contralateral peripheral nerves and contralateral genital skin on day 4 or 5 although lesions were only rarely detected on the contralateral side. Genital skin lesions first developed on day 5 and were followed by the development of lesions along the medial aspect of the ipsilateral hindlimb. Virus was first detected in the vaginal vault on day 4 or 5. The development of lesions appeared to be unrelated to vaginal virus replication but was associated with the recovery of virus from peripheral nerves. Recurrent genital skin lesions were seen more commonly on the inoculated side than the contralateral side. Since the development of skin lesions appeared to result from virus emerging from nerve endings, an event similar to the terminal event that is believed to be involved in the development of recurrent lesions, we now have a model which may be useful in further exploring the pathogenesis of herpetic disease.
INTRODUCTION
Understanding the pathogenesis of genital herpes simplex virus type 2 (HSV-2) infection is critical to the development of strategies for the control of this common infection. If, as we originally proposed (Stanberry et al., 1982 (Stanberry et al., , 1985 the genital lesions that develop after intravaginal inoculation in guinea-pigs result from virus replication at central neural sites, then it is probable that by the time patients seek medical attention for genital lesions, virus has already infected the dorsal root ganglia, the site of latent infection. Antiviral therapy given at this time, therefore, would be unlikely to prevent, although it could modify, the development of latent infection and hence the pattern of recurrent disease. Indeed, this appears to be the situation with the most effective drug currently available, acyclovir (Bryson et al., 1983a, b; Bernstein et al., 1986) .
To test our hypothesis that symptomatic genital infection is preceded by central neural replication and to add to our understanding of the pathogenesis of this disease, we developed a model of genital HSV-2 infection that anatomically separates the site of initial viral replication from secondary replication (after virus emerges from neural tissue) in the vagina. This approach has already proved successful in the evaluation of HSV-1 infections in a mouse model (Blyth et al., 1984) and has provided evidence that immune control at the site of inoculation could be different from that which controls viral multiplication at sites infected via neural spread (Simmons & Nash, 1984 , 1985a .
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Cells and virus.
First to third passage rabbit kidney (RK) cells were prepared from the kidney of 3-week-old pasteureUa-free female New Zealand white rabbits as previously described (Stanberry et al., 1985) . Rabbit skin cells were obtained from Dr J. Stevens (UCLA Medical Center, Los Angeles, Ca., U.S.A.). Clarified pools of the MS (ATCC VR-540) strain of HSV-2 were prepared in RK cells and stored frozen at -70 °C.
Animals. Female Hartley guinea-pigs (Charles River Breeding Laboratories, Wilmington, Mass., U.S.A.) weighing 250 to 300 g and female strain 2 guinea-pigs (Children's Hospital Research Foundation, Cincinnati) weighing 500 to 600 g were used.
Inoculation. Animals were treated the day prior to viral inoculation with a chemical depilatory, Nair (Carter Products, New York, U.S.A.), on the ventral surface from mid-abdomen down. To inoculate animals, an area approximately 5 mm 2 located 1 cm posterior and lateral to the external genital skin [the skin sparsely covered with fine hairs that surrounds and includes the perineum (Stanberry et al., 1982) ] was scarified with a 27-gauge needle and 10 vtl containing 104.7 p.f.u. HSV-2 was applied, followed by further abrasion.
Experimentaldesign. In the first experiment, 30 strain 2 animals were inoculated and three animals per day were sacrificed on days 1 to 6, 8 and 10. In experiment two, 22 Hartley guinea-pigs were inoculated and three animals per day sacrificed on days 1 to 5,7 and 9. Swab specimens of the vaginal vault were obtained daily for viral titration and animals were also evaluated daily for skin lesions, urinary retention and hindlimb paralysis. In experiment three, 10 Hartley animals were inoculated and evaluated daily as above except that vaginal swabs were not obtained. After recovery from the primary infection (day 14) animals were examined daily for 55 of the next 60 days for evidence of recurrent vesicular lesions. A new recurrence was scored when a lesion appeared after at least 1 lesion-free day.
Isolation of virus. Vaginal swab specimens were obtained with a premoistened calcium alginate-tipped swab which was placed in 1.0 ml MEM containing penicillin (100 units/ml), streptomycin (50 ~tg/ml), gentamicin (50 ~tg/ml) and amphotericin B (2.5 Ixg/ml) and frozen at -70 °C until assayed. To obtain tissue samples, animals were sacrificed by CO2 narcosis and exsanguinated. The square of inoculated skin was homogenized in 1.0 ml MEM as were equal-sized samples of the ipsilateral and contralateral external genital skin. The lumbosacral dorsal root ganglia and approximately equal-sized portions of the ipsilateral and contralateral ischial nerve, genitofemoral and femoral nerves combined, were homogenized separately in 1.0 ml MEM. A 10~ homogenate of the lumbosacral spifi~il cord was also prepared in MEM. In experiment 1, specimens were frozen immediately after homogenization and stored at -70 °C. From each specimen, 0.2 ml was then inoculated onto tubes of RK cells and 0.2 ml was titrated on 60 mm Petri dishes of rabbit skin ceils with an agarose overlay. Tubes were observed for 10 days for c.p.e, while the titration dishes were strained with crystal violet after 72 h incubation at 37 °C. In experiment 2 both tubes and dishes were inoculated immediately after homogenization. If c.p.e, was noted in tubes but no plaques were observed, a titre of 5 p.f.u./ml was used for calculation of the mean titre.
RESULTS
Clinical course
In experiment 1, vesicular lesions were observed in four animals on day five. These animals exhibited one to three vesicles on the ipsilateral (to the inoculation site) external genital skin (three animals) or near the abraded area (two animals). By day six, 12 of the 15 remaining animals had developed lesions. All but one animal had lesions on the ipsilateral external genital skin (range one to four lesions) and lesions extended down the medial aspect of the ipsilateral thigh in a zosteriform distribution. The maximum extent of lesions was noted on day 7 or 8. At this time, the ipsilateral external genital skin had between one and six lesions that were becoming confluent and ulcerative. Lesions extended from about 2 cm cephalad of the genitalia on the abdomen and down the entire extent of the medial aspect of the leg. Lesions were also seen posterior to the external genital skin on the ipsilateral side. No animal developed lesions anywhere on the contralateral side. Nine animals developed urinary retention on day 7 or 8 and four of six animals not sacrificed died between days 12 and 16.
In experiment 2, vesicular lesions appeared on the posterior ipsilateral quadrant of the external genital skin on day 4 in four animals ( Fig. 1) . By day 5 all 10 remaining animals had developed lesions on the ipsilateral external genital skin with a range of one to four lesions. Seven animals also exhibited lesions extending down the medial aspect of the leg and/or posterior to the external genital skin (Fig. 1) . The extent of lesions was greatest on day 6 or 7 with ipsilateral genital skin lesions becoming confluent and ulcerative. On day 7 one animal developed a single lesion on the contralateral external genital skin and several lesions extending (Fig. 1) . Two animals developed ipsilateral hindlimb paralysis on day 7 and six developed urinary retention on day 6 or 7.
Experiment 3 was performed to eliminate the possibility that swabbing the vaginal vault introduced HSV into the vagina, and to follow animals for recurrent disease. Results similar to those of the first two experiments were obtained. On day five, eight of 10 animals developed ipsilateral vesicular lesions while on day 6 all animals had lesions on the ipsilateral external genital skin and all but one also exhibited lesions extending down the ipsilateral leg. Two animals developed lesions on the contralateral side, one on day 7 and one on day 12. The lesion on day 12 might be considered a recurrence since it appeared 6 days after the only day on which this animal had lesions on the ipsilateral side. Seven animals developed urinary retention on day 6 or 7 and two hindlimb paralysis on day 7.
Nine of the 10 animals developed from one to five recurrences. Eighteen recurrences occurred in seven animals on the ipsilateral side and seven occurred in six animals on the contralateral side. Four animals therefore had recurrences on the contralateral side although no lesions were noted on this side during the acute infection of the animal.
Relationship of vaginal replication to genital lesions
In experiment 1, virus was first detected in the vaginal vault of one animal on day 3 but not until day 5 in the remainder of the animals (Table 1) . Genital lesions were first detected on the same day that vaginal virus was first isolated in six of 12 animals, the day after vaginal virus was first detected in one of 12, and the day before in one of 12. Four animals developed genital lesions although virus was never isolated from vaginal swabs. In experiment 2, virus was first detected in the vaginal vault on day 5. Genital lesions were first noted on the same day on which virus was first detected in the vaginal vault in five of 11 animals, before lesions developed in three of 11 animals and in three animals in which virus was not isolated from the vaginal vault.
Spread of virus
In experiment 1, virus was isolated from the inoculation site from days 1 to 10 (Table 2) . Titres peaked on day 2 and remained constant until day 6. By day 10 only one of three tissue samples had virus present. Other than at the inoculation site, virus was first detected in the ipsilateral genital skin of one animal on day 2 and in the peripheral nerve and ipsilateral genital skin of one animal on day 3. By day 4 and up to day 8 virus was recovered from the lumbosacral spinal cord, peripheral nerve and ipsilateral genital skin. Virus was consistently isolated from the genital skin (11 animals) only in those guinea-pigs where it was also detected in peripheral nerve (nine of the 11) and the central nervous system (nine of 11). Virus was isolated from the genital skin 1 to 4 days before lesions were noted. 
C•inical disease and is••ati•n •f HSV fr•m tissues and the vaginal vault f•ll•wing peripheral inoculation of strain 2 guinea-pigs
No. of animals with virus isolated per day after inoculation (n = 3/day) In experiment 2 a more complete examination was performed to determine the ipsilateral and contralateral involvement of the nervous system and genital skin (Table 3 ). Viral recovery from the site of inoculation was similar to experiment 1. Virus was first detected in the ipsilateral peripheral nerve on day 2. As in experiment 1, virus was detected in the genital skin of one animal (day 3) before virus was isolated from any nervous tissue. Virus was isolated as early as day 3 from the ipsilateral dorsal root ganglia (DRG) and spinal cord. Viral titres in the peripheral nerves, DRG and spinal cord were approximately equal during the first 7 days after infection. Virus was isolated from the ipsilateral genital skin 2 days and from the contralateral genital skin 3 days before lesions were noted on the respective side.
There was a strong correlation between the recovery of virus in the genital skin of either side and the detection of virus in the peripheral nerve, DRG and spinal cord of that animal. Only one isolate from the ipsilateral genital skin was not accompanied by isolation from the peripheral nerve, DRG or spinal cord (day 3) and only two other viral isolations (day 9) were made without the simultaneous recovery from the peripheral nerves. Likewise, on the contralateral side, viral (1"7) (3'7) (4"9) (3'9) (1"3) 0 0 2 1 1 (3'8)
(
(1.0) (1.2) (2.2) (2-1) 0 0 0 0 0 * Geometric mean titre from tissue sample with virus present expressed as loglo/ml of supernatant. t Femoral nerve may include portions of the genitofemoral nerve. ~t The letter designation denotes the same animal had virus isolated from the indicated tissue.
isolation from the genital skin was made in the absence of virus from the peripheral nerve only on day 9 (one animal) and from the DRG only on day 7 (one animal) and on day 9. Virus was isolated from the contralateral genital skin of nine of the 12 animals sacrificed after day 3 although lesions were only rarely seen on this side. The contralateral DRG were infected by day 4 although virus was not detected in the vaginal vault until day 5 and therefore this was probably the result of virus spread through the central nervous tissue.
DISCUSSION
From these results we propose the following scheme. Virus replicates at the inoculation site and enters peripheral nerves early in infection (day 2). Virus then ascends via peripheral nerves to the DRG (ipsilateral) and spinal cord (day 3). Isolation of virus from peripheral nerves prior to ganglionic infection indicates virus is present in an infectious form. This is consistent with previous reports in guinea-pigs (Scriba, 1976; Stanberry et al., 1982) but differs from findings in mice (Klein & DeStefano, 1983) and from in vitro studies of rat neurons (Lycke et al., 1984) .
It is also possible that virus may descend down neural pathways before it reaches the DRG or spinal cord. This would account for the detection of virus in the genital skin prior to the time it has ascended to the DRG or spinal cord. In a previous report (Stanberry et al., 1982) similar findings were noted, although it was thought that the isolation of HSV-2 from the genital skin prior to day 4 was the result of contamination from the vaginal vault. Although a similar explanation might also account for the present results the possibility that virus can descend though peripheral nerves before it has reached DRG cannot be excluded. If this hypothesis is correct it would also suggest that virus spreads from within the peripheral nervous tissue, possibly via branched motor neurons (Openshaw & Ellis, 1983) or autonomic nerves (Price et al., 1975) .
Once virus has entered the DRG and spinal cord it may descend to the genital skin (day 3) and vaginal vault (day 4) where it causes vesicular skin lesions (days 4 to 6) or cervicovaginal infection. Our results also indicate that virus can cross from the ipsilateral to the contralateral DRG, most probably by replication within the spinal cord. Thus, virus can be detected on day 4 in the contralateral DRG, the same time at which it is first recovered in the vaginal vault and the contralateral peripheral nerves. Previous work assessing the involvement of the contralateral ganglia is scarce. Klein & DeStefano (1983) reported infection of seven of 20 contralateral ganglia 4 days after footpad inoculation of HSV-I in mice and in 17 of 20 animals after 7 days. Since it is possible that HSV reaches the vaginal mucosa after footpad inoculation, it is uncertain how many of these contralateral ganglia may have been infected by an ascending route after replication in the vaginal vault. Tullo et al. (1982) reported infection of the contralateral brainstem on days 5 to 7 in all three mice sacrificed on these days after corneal inoculation, while Simmons & Nash (1985b) reported isolation of HSV-1 from contralateral trigeminal ganglia only in immunosuppressed mice 8 days after percutaneous infection. Gerdes & Smith (1983) demonstrated that infection of the contralateral eye and ganglia of rabbits following corneal infection depended on the strain of virus inoculated, with HSV-2 strains in general more likely to exhibit crossover infection.
From the vaginal vault virus may enter peripheral nerves in the ipsilateral and contralateral sides and then ascend to the DRG and spinal cord where it may follow a course similar to that seen after primary vaginal inoculation, i.e. descend and cause ipsilateral or contralateral lesions. Although virus was frequently (nine of 12 animals sacrificed after day 3) isolated from the contralateral genital skin, lesions were only rarely seen on this side. We speculate, therefore, that some immunological event active early in infection is capable of preventing the development of most lesions although virus has escaped from neural tissue and replicated to low levels. Recurrences also occurred less frequently on the contralateral side, a finding similar to that reported by Gerdes & Smith (1983) following corneal infection. While these investigators felt that recurrences may be less frequent when the virus spreads to the opposite trigeminal ganglia from within the central nervous system it is also possible that the number of latently infected neurons on each side at least partly determines the recurrence rates.
The use of this model has permitted us to separate anatomically the initial replication site of virus (abraded area) from secondary sites that are seeded by virus as it escapes from neural tissue (genital skin lesions, cervicovaginal infection). Thus, we have been able to show that genital skin lesions can occur in the absence of vaginal viral replication but that their development correlates with infection of the DRG and peripheral nerves that innervate this area. These results provide further support for our original hypothesis (Stanberry et al., 1982 (Stanberry et al., , 1985 that after intravaginal inoculation the virus responsible for external skin lesions arrives at the genital skin via peripheral nerves. Similarly, the same mechanism explains the observations that after intravaginal inoculation guinea-pigs develop vesicular lesions in their footpads (Scriba & Tatzber, 1981) and that a similar distribution of lesions as seen in the zosteriform model can be observed in animals depilated and inoculated intravaginally (unpublished observations).
Since the final event in recrudescent disease is also thought to involve descent of virus from the DRG, escape from peripheral nerve endings and local replication in the epidermis, there is renewed interest in the investigation of zosteriform spread (Blyth et al., 1984; Simmons & Nash, 1984 , 1985a . A model of zosteriform HSV-1 spread in mice has already demonstrated differences between the immune mechanisms that are effective in viral elimination from the primary as compared to secondary sites of replication (Simmons & Nash, 1984 , 1985a . We believe the model described in this report will be of value in evaluating the immunobiology of recurrent genital HSV-2 infection.
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